CHONGQING PHARMACEUTICAL GROUP — Oseltamivir Importer Profile
Pharmaceutical Importer · #15 buyer for Oseltamivir · $650.0K import value · 13 shipments · CHINA · DGFT Verified
CHONGQING PHARMACEUTICAL GROUP is the #15 importer of Oseltamivir from India with $650.0K in import value and 13 verified shipments. CHONGQING PHARMACEUTICAL GROUP holds a 0.6% market share in Oseltamivir imports based in CHINA. The company sources from 1 verified supplier across 7 formulations shipped to 1 country.
CHONGQING PHARMACEUTICAL GROUP — Oseltamivir Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Oseltamivir to CHONGQING PHARMACEUTICAL GROUP?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| NATCO PHARMA LIMITED | $650.0K | 13 | 100.0% |
CHONGQING PHARMACEUTICAL GROUP sources Oseltamivir from 1 verified Indian supplier based on 13 customs records. The primary supplier is NATCO PHARMA LIMITED accounting for 100.0% of imports.
How Does CHONGQING PHARMACEUTICAL GROUP Compare to Nearest Oseltamivir Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | CHONGQING PHARMACEUTICAL (GROUP) CO | CHINA | $700.0K | 14 | $50.0K |
| 17 | STRIDES PHARMA INC, | UNITED STATES | $700.0K | 14 | $50.0K |
| 15 | CHONGQING PHARMACEUTICAL GROUP ★ | CHINA | $650.0K | 13 | $50.0K |
| 14 | J KNIPPER COMPANY | UNITED STATES | $600.0K | 12 | $50.0K |
| 18 | CHONGQING PHARMACEUTICAL(GROUP) CO. | CHINA | $500.0K | 10 | $50.0K |
CHONGQING PHARMACEUTICAL GROUP ranks #15 among 314 Oseltamivir importers from India. Average shipment value of $50.0K compared to the market average of $57.8K. The closest competitors by value are CHONGQING PHARMACEUTICAL (GROUP) CO and STRIDES PHARMA INC,.
Where Does CHONGQING PHARMACEUTICAL GROUP Import Oseltamivir To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CHINA | $650.0K | 13 | 100.0% |
CHONGQING PHARMACEUTICAL GROUP imports Oseltamivir to 1 country. The primary destination is CHINA receiving 100.0% of shipments worth $650.0K.
What Oseltamivir Formulations Does CHONGQING PHARMACEUTICAL GROUP Import?
| Formulation | Value | Shipments |
|---|---|---|
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384 X 10S OTHER REF CI NO: 123161APPENDIX 4R, RODTEP ENTRY NO: 10153 | $150.0K | 3 |
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 70464X 10S OTHER REF CI NO: 123162APPENDIX 4R, RODTEP ENTRY NO: 10153 | $150.0K | 3 |
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384X 10S OTHER REF CI NO: 123163APPENDIX 4R, RODTEP ENTRY NO: 10153 | $150.0K | 3 |
| OSELTAMIVIR PHOSPHATE CAPSULES 75MG 10S 95136 X 10S OTHER REF CI NO: 123056APPENDIX 4R RODTEP ENTRY NO: 10153 | $50.0K | 1 |
| OSELTAMIVIR PHOSPHATE CAPSULES 75MG 10S 96672 X 10S OTHER REF CI NO: 123058APPENDIX 4R RODTEP ENTRY NO: 10153 | $50.0K | 1 |
| OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72192 X 10S OTHER REF CI NO: 123055APPENDIX 4R RODTEP ENTRY NO: 10153 | $50.0K | 1 |
| OSELTAMIVIR PHOSPHATE CAPSULES 75MG 10S 97248 X 10S OTHER REF CI NO: 123057APPENDIX 4R RODTEP ENTRY NO: 10153 | $50.0K | 1 |
CHONGQING PHARMACEUTICAL GROUP imports 7 distinct Oseltamivir formulations from India. The top formulation is OSELTAMIVIR PHOSPHATE CAPSULES 30MG 10S 72384 X 10S OTHER RE with 3 shipments worth $150.0K.
Who Are the Top Buyers of Oseltamivir from India and How Much Does CHONGQING PHARMACEUTICAL GROUP Import?
India exported $18.1M worth of Oseltamivir through 2,149 shipments from 118 suppliers to 79 countries, serving 314 buyers globally. CHONGQING PHARMACEUTICAL GROUP imports $650.0K of this total, accounting for 0.6% of India's Oseltamivir exports with 13 shipments from CHINA. This is verified from 13 customs shipment records covering 7 distinct formulations.
What Is the Average Order Value for CHONGQING PHARMACEUTICAL GROUP's Oseltamivir Imports?
CHONGQING PHARMACEUTICAL GROUP's average Oseltamivir order value is $50.0K per consignment, based on 13 shipments totaling $650.0K. CHONGQING PHARMACEUTICAL GROUP is based in CHINA and ranks #15 among all Oseltamivir importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Oseltamivir to CHONGQING PHARMACEUTICAL GROUP?
CHONGQING PHARMACEUTICAL GROUP sources Oseltamivir from 1 verified Indian supplier: NATCO PHARMA LIMITED ($650.0K, 100.0%). This is based on 13 customs records.
How Does CHONGQING PHARMACEUTICAL GROUP Compare to Other Oseltamivir Importers?
CHONGQING PHARMACEUTICAL GROUP ranks #15 among 314 Oseltamivir importers from India with a 0.6% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($4.4M), NATCO PHARMA (CANADA) INC ($3.0M), AMNEAL PHARMACEUTICALS, LLC (KY) ($2.4M). CHONGQING PHARMACEUTICAL GROUP processed 13 shipments from CHINA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oseltamivir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oseltamivir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CHONGQING PHARMACEUTICAL GROUP matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CHONGQING PHARMACEUTICAL GROUP's capped import value divided by total capped export value for Oseltamivir across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching CHONGQING PHARMACEUTICAL GROUP importing Oseltamivir, covering 7 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 79+ countries, 314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oseltamivir Import Data for CHONGQING PHARMACEUTICAL GROUP
Access order-level details, pricing data, supplier connections, and competitive analysis for CHONGQING PHARMACEUTICAL GROUP's Oseltamivir imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CHONGQING PHARMACEUTICAL GROUP
Company Profile
Multiple products · $0 total trade · Multiple categories
CHONGQING PHARMACEUTICAL GROUP × Oseltamivir
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CHONGQING PHARMACEUTICAL GROUP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oseltamivir. For current order-level data, contact TransData Nexus.